Regulation of mevalonate synthesis in rat mammary glands by dietary n-3 and n-6 polyunsaturated fatty acids

Cancer Research

Volumn 57, Issue 17, 1997, Pages 3685-3687

  El Sohemy, Ahmed ^a   Archer, Michael C ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MEVALONIC ACID; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; SAFFLOWER OIL;

AMINO ACID SYNTHESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DIETARY INTAKE; DNA SYNTHESIS INHIBITION; ENZYME ACTIVITY; FAT INTAKE; GROWTH REGULATION; INTERNALIZATION; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ACYL COENZYME A; ANIMALS; CHOLESTEROL; FATTY ACIDS, UNSATURATED; FEMALE; FISH OILS; MAMMARY GLANDS, ANIMAL; MEVALONIC ACID; RATS; RATS, SPRAGUE-DAWLEY; SAFFLOWER OIL;

EID: 0030865838     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Caygill, C. P. J., Charlett, A., and Hill, M. J. Fat, fish, fish oil and cancer. Br. J. Cancer, 74: 159-164, 1996.
2. Kaizer, F., Boyd, N. F., Kriukow, V., and Trichler, D. Fish consumption and breast cancer risk: an ecological study. Nutr. Cancer, 12: 61-68, 1989.
3. Dolecek, T. A., and Granditis, G. Dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial (MRFIT). World Rev. Nutr. Diet, 66: 205-216, 1991.
4. Carroll, K. K., and Braden, L. M. Dietary fat and mammary carcinogenesis. Nutr. Cancer, 6: 254-259, 1985.
5. Karmali, R. A., Marsh, J., and Fuchs, C. Effect of ω-3 fatty acids on growth of a rat mammary tumor. J. Natl. Cancer Inst., 73: 457-461, 1984.
6. Cohen, L. A., Chen-Backlund, J-Y., Sepkovic, D. W., and Sugie, S. Effect of varying proportions of dietary menhaden and corn oil on experimental rat mammary tumor promotion. Lipids, 28: 449-456, 1993.
7. Rose, D. P., and Connolly, J. M. Effects of fatty acids and inhibitors of eicosanoid synthesis on the growth of a human breast cancer cell line in culture. Cancer Res., 50: 7139-7144, 1990.
8. Welsch, C. W. Enhancement of mammary tumorigenesis by dietary fat: review of potential mechanisms. Am. J. Clin. Nutr., 45: 192-202, 1987.
9. Welsch, C. W. Relationship between dietary fat and experimental mammary tumorigenesis: a review and critique. Cancer Res., 52 (Suppl.): 2040s-2048s, 1992.
10. Goodwin, P. J., Boyd, N. F., Hanna, W., Hartwick, W., Murray, D., Qizilbash, A., Redwood, S., Hood, N., DelGuidice, M. E., Sidlofsky, S., McCready, D., Wilkinson, R., Mahoney, L., Connelly, P., and Page, D. L. Elevated levels of plasma triglycerides are associated with histologically defined premenopausal breast cancer risk. Nutr. Cancer, 27: 284-292, 1997.
11. El-Sohemy, A., Bruce, W. R., and Archer, M. C. Inhibition of rat mammary tumorigenesis by dietary cholesterol. Carcinogenesis (Lond.), 17: 159-162, 1996.
12. Gabriel, H. F., Melhem, M. F., and Rao, K. N. Enhancement of DMBA-induced mammary cancer in Wistar rats by unsaturated fat and cholestyramine. In Vivo, 1: 303-308, 1987.
13. Klurfeld, D. M., and Kritchevsky, D. Serum cholesterol and 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis. Cancer Lett., 14: 273-278, 1981.
14. Harris, W. S. n-3 fatty acids and serum lipoproteins: animal studies. Am. J. Clin. Nutr., 65 (Suppl.): 1611s-1616s, 1997.
15. Goldstein, J. L., and Brown, M. S. Regulation of the mevalonate pathway. Nature (Lond.), 343: 425-430, 1990.
16. Fairbanks, K. P., Witte, L. D., and Goodman, D. S. Relationship between mevalonate and mitogenesis in human fibroblasts stimulated with platelet-derived growth factor. J. Biol. Chem., 259: 1546-1551, 1984.
17. Siperstein, M. D. Cholesterol, cholesterogenesis and cancer. Adv. Exp, Med. Biol., 369: 155-166, 1995.
18. Huneeus, V. Q., Wilely, M. H., and Siperstein, M. D. Essential role for mevalonate synthesis in DNA replication. Proc. Natl. Acad. Sci. USA, 76: 5056-5060, 1979.
19. Elson, C. Suppression of mevalonate pathway activities by dietary isoprenoids: protective roles in cancer and cardiovascular disease. J. Nutr., 125: 1666s-1672s, 1995.
20. Larsson, O. Effects of isoprenoids on growth of normal human mammary epithelial cells and breast cancer cells in vitro. Anticancer Res., 14: 123-128, 1994.
21. Bennis, F., Favre, G., Le Gaillard, F., and Soula, G. Importance of mevalonate-derived products in the control of HMG-CoA reductase activity and growth of human lung adenocarcinoma cell line A549. Int. J. Cancer, 55: 640-645, 1993.
22. Soma, M. R., Baetta, R., De Renzis, M. R., Mazzini, G., Davegna, C., Magrassi, L., Butti, G., Pezzotta, S., Paoletti, R., and Fumagalli, R. In vivo enhanced antitumor activity of carmustine [N,N′-bis(2-chloroethyl)-N-nitrosourea] by simvastatin. Cancer Res., 55: 597-602, 1995.
23. Narisawa, T., Fukaura, Y., Terada, K., Umezawa, A., Tanida, N., Yazawa, K., and Ishikawa, C. Prevention of 1,2-dimethylhydrazine induced colon tumorigenesis by HMG-CoA reductase inhibitors, pravastatin and simvastatin, in ICR mice. Carcinogenesis (Lond.), 15: 2045-2048, 1994.
24. Choi, Y-S., Goto, S., Ikeda, I., and Sugano, M. Effect of dietary n-3 polyunsaturated fatty acids on cholesterol synthesis and degradation in rats of different ages. Lipids, 24: 45-50, 1989.
25. Clarke, P. R., and Hardie, D. G. Regulation of HMG-CoA reductase: identification of the site phosphorylated by the AMP-activated protein kinase in vitro in intact rat liver. EMBO J., 9: 2439-2446, 1990.
26. Shand, J. H., and West, D. W. Effects of an antiserum to rat growth hormone and bromocriptine on cholesterol-metabolizing enzymes in the lactating rat mammary gland. J. Endocrinol., 128: 287-295, 1991.
27. Reeves, P. G., Nielsen, F. H., and Fahey, G. C., Jr. AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad Hoc Writing Committee on the Reformulation of the AIN-76A Rodent Diet. J. Nutr., 123: 1939-1951, 1993.
28. Ness, G. C., Pendleton, L. C., and Pendleton, A. S. Loss of NADPH during assays of HMG-CoA reductase: implications and approaches to minimize errors. Lipids, 22: 409-412, 1987.
29. Ness, G. C., Sample, C. E., Smith, M., Pendleton, A. S., and Eichler, D. C. Characteristics of rat liver microsomal 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Biochem. J., 233: 167-172, 1986.
30. Rao, K. N., Melhem, M. F., Gabriel, H. F., Eskander, E. D., Kazanecki, M. E., and Amenta, J. S. Lipid composition and de novo cholesterogenesis in normal and neoplastic rat mammary tissues. J. Natl. Cancer Inst., 80: 1248-1253, 1988.
31. Chen, H. W., Kandutsch, A. A., and Heiniger, H. J. The role of cholesterol in malignancy. Prog. Exp. Tumor Res., 22: 275-316, 1978.
32. Der, C. J., and Cox, A. D. Isoprenoid modification and plasma membrane association: critical factors for Ras oncogenicity. Cancer Cells, 3: 331-340, 1991.
33. Kohl, N. E., Mosser, S. D., deSolms, J., Giuliani, E. A., Pompliano, D. L., Graham, S. L., Smith, R. L., Scolnick, E. M., Oliff, A., and Gibbs, J. B. Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor. Science (Washington DC), 260: 1934-1937, 1993.
34. Singh, J., Hamid, R., and Reddy, B. S. Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer. Cancer Res., 57: 253-258, 1997.
35. Anderson, J. M., and Dietschy, J. M. Regulation of sterol synthesis in 15 tissues of rat. J. Biol. Chem., 252: 3652-3659, 1977.
36. Brown, M. S., and Goldstein, J. L. A receptor-mediated pathway for cholesterol homeostasis. Science (Washington DC), 232: 34-47, 1986.